Free Soft Tissue Graft in Treatment of Oral Lichen Planus
NCT ID: NCT00737854
Last Updated: 2008-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
20 participants
INTERVENTIONAL
2008-05-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
According to other authors, basal epithelial layers of the graft remain intact and represent the focus of re-epithelization. New epithelial cells migrate over the basal membrane and appear to guide it by proliferation, will generate new epithelium. The wound is re-epithelialized by proliferation of surrounding healthy epithelial cell, therefore, not contaminated by modified antigens of the cell membrane that are theoretically responsible for lymphocyte aggression. The healthy graft remains free of lesions and appears clinically healthy.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
According to other authors, basal epithelial layers of the graft remain intact and represent the focus of reepithelialization. new epithelial cell migrate over the basal membrane and appear to guide it and by proliferation ,will generate new epithelium. so the wound is re-epithelialized by proliferation of surrounding healthy epithelial cell, therefore, not contaminated by modified antigens of the cell membrane that are theoretically responsible for lymphocyte aggression so the healthy graft remains free of lesions and appears clinically healthy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 ARM
Otherwise healthy patients with oral lichen planus (precancerous/erosive OLP)
Surgical resection
20 patients with OLP will be selected for this study. Before this routine treatment modalities had been attempted. Removal of possible triggering drug was also considered. Local ethical committee approval will be obtained before the trial starts. Surgical procedure includes: removal of the tissue up to submucosa (containing antigenic properties that caused OLP). A specimen will be sent for histopathologic analysis. The graft sliced from healthy mucosa also up to submucosa. Then the graft trimmed on a gauze soaked in saline and adapted to recipient site. The graft was sutured in position. Checking will be done after 1 week and every two months up to 1 year. Punch biopsy will be done in 1 year after surgery for histopathologic investigations.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgical resection
20 patients with OLP will be selected for this study. Before this routine treatment modalities had been attempted. Removal of possible triggering drug was also considered. Local ethical committee approval will be obtained before the trial starts. Surgical procedure includes: removal of the tissue up to submucosa (containing antigenic properties that caused OLP). A specimen will be sent for histopathologic analysis. The graft sliced from healthy mucosa also up to submucosa. Then the graft trimmed on a gauze soaked in saline and adapted to recipient site. The graft was sutured in position. Checking will be done after 1 week and every two months up to 1 year. Punch biopsy will be done in 1 year after surgery for histopathologic investigations.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Previous routine treatment modalities has been attempted including steroids and immunomodulatory or antioxidant agents. i.e patients who had resistant lesions to routine treatment .removal of possible triggering drugs was also considered.
* Patients of both sexes between 40 to 70 year's old
* Patients who have symptoms such as burning sensation, pain
* Patients who have localized precancerous lesions such as atrophic-erosive/plaque like lichen planus with diameter lesser than 2 cm
* Patients who agree to this treatment
* Patients who are willing for evaluation in first week after surgery and every two month for 1 years
* Patients who agree to final punch biopsy for histopathologic evaluation
Exclusion Criteria
* Patients suffering from any localized or systemic disease
* Pregnant patients
* Smokers
* Patients who can not continue the study for private or social reasons
* Patients with generalized oral lichen planus
40 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qazvin University Of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Qazvin University Of Medical Sciences . Deputy of Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Farshid Rayati, DDS
Role: STUDY_DIRECTOR
Qazvin University Of Medical Sciences
Tuba(Aida) Karagah, DDS
Role: PRINCIPAL_INVESTIGATOR
QUMS
Farshid Rayati, DDS
Role: STUDY_CHAIR
QUMS
Saeid Asefzadeh, PHD
Role: STUDY_CHAIR
QUMS
Poopak masumi, DDS-MS
Role: STUDY_DIRECTOR
QUMS
pourya falah, student
Role: PRINCIPAL_INVESTIGATOR
QUMS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qazvin University of Medical Sciences
Qazvin, Qazvin State, Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Farshid Rayati, DDS
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACTG022
Identifier Type: -
Identifier Source: org_study_id